Tokio Marine Asset Management Co. Ltd. increased its holdings in Danaher Co. (NYSE:DHR – Free Report) by 4.5% in the 3rd quarter, Holdings Channel reports. The fund owned 18,812 shares of the conglomerate’s stock after purchasing an additional 807 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in Danaher were worth $5,230,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. CarsonAllaria Wealth Management Ltd. purchased a new stake in shares of Danaher in the second quarter worth approximately $25,000. nVerses Capital LLC acquired a new position in Danaher in the 2nd quarter valued at approximately $25,000. MFA Wealth Advisors LLC purchased a new stake in Danaher in the 2nd quarter worth approximately $51,000. Financial Connections Group Inc. purchased a new position in shares of Danaher during the 2nd quarter valued at $51,000. Finally, Western Pacific Wealth Management LP purchased a new stake in shares of Danaher during the first quarter worth $55,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Danaher Stock Performance
NYSE:DHR traded down $2.39 during mid-day trading on Thursday, hitting $239.14. The stock had a trading volume of 199,060 shares, compared to its average volume of 2,734,626. Danaher Co. has a twelve month low of $204.15 and a twelve month high of $281.70. The company’s 50 day simple moving average is $263.42 and its 200 day simple moving average is $260.64. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The stock has a market cap of $172.72 billion, a price-to-earnings ratio of 46.08, a PEG ratio of 4.40 and a beta of 0.85.
Danaher Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were paid a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a yield of 0.45%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.
Insider Buying and Selling at Danaher
In other news, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the sale, the senior vice president now owns 4,212 shares of the company’s stock, valued at approximately $1,130,374.44. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 11.10% of the company’s stock.
Analyst Ratings Changes
Several equities research analysts have recently issued reports on DHR shares. KeyCorp lifted their price target on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Leerink Partners lifted their price objective on shares of Danaher from $275.00 to $280.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Robert W. Baird reduced their target price on Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Evercore ISI upped their target price on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. Finally, Wolfe Research upgraded shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a research report on Thursday, October 31st. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $287.16.
View Our Latest Stock Analysis on Danaher
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- What is the Euro STOXX 50 Index?
- Top 3 R&D-Driven Stocks Showing Strong Profit and Momentum
- What Are Dividend Achievers? An Introduction
- Shopify Stock Rally Continues: Why the Growth Story Isn’t Over
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Tariff Troubles: 3 Stocks Planning Higher Prices
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.